Display options
Cite
Caracò C, Marone U, Simeone E, et al. Electrochemotherapy in melanoma patients: a single institution experience. Melanoma Manag. 2015;2(2):127-132doi: 10.2217/mmt.15.9.
Caracò, C., Marone, U., Simeone, E., Grimaldi, A. M., Botti, G., Del Giudice, M., Ascierto, P. A., & Mozzillo, N. (2015). Electrochemotherapy in melanoma patients: a single institution experience. Melanoma management, 2(2), 127-132. https://doi.org/10.2217/mmt.15.9
Caracò, Corrado, et al. "Electrochemotherapy in melanoma patients: a single institution experience." Melanoma management vol. 2,2 (2015): 127-132. doi: https://doi.org/10.2217/mmt.15.9
Caracò C, Marone U, Simeone E, Grimaldi AM, Botti G, Del Giudice M, Ascierto PA, Mozzillo N. Electrochemotherapy in melanoma patients: a single institution experience. Melanoma Manag. 2015 May;2(2):127-132. doi: 10.2217/mmt.15.9. Epub 2015 May 18. PMID: 30190842; PMCID: PMC6094613.
Copy Download .nbib Format: NLM
Share it on

Melanoma Manag. 2015 May;2(2):127-132. doi: 10.2217/mmt.15.9. Epub 2015 May 18.

Electrochemotherapy in melanoma patients: a single institution experience.

Melanoma management

Corrado Caracò, Ugo Marone, Ester Simeone, Antonio Maria Grimaldi, Gerardo Botti, Maurizio Del Giudice, Paolo Antonio Ascierto, Nicola Mozzillo

Affiliations

  1. Melanoma Department, Istituto Nazionale Tumori 'Fondazione Pascale' Napoli, Italy.
  2. Division of Pathology, Istituto Nazionale Tumori 'Fondazione Pascale' Napoli, Italy.
  3. Division of Anesthesiology, Istituto Nazionale Tumori 'Fondazione Pascale' Napoli, Italy.

PMID: 30190842 PMCID: PMC6094613 DOI: 10.2217/mmt.15.9

Abstract

AIM: This study was undertaken to update the outcome of the treated lesions with electrochemotherapy (ECT) plus intravenous injection of bleomycin in patients with in-transit disease or distant cutaneous metastases in melanoma patients.

PATIENTS & METHODS: 89 patients with relapsed and refractory cutaneous melanoma metastases or in-transit disease were submitted to 126 treatments of ECT.

RESULTS: 34 patients (38.2%) had a partial response and 43 had a complete response (48.3%). 12 patients (13.5%) had no change or progressive disease. The objective response rate was 67.5%.

CONCLUSION: The favorable outcome obtained in the present study demonstrates that ECT is a reliable, easy, fast and effective procedure showing benefits in terms of curative and palliative treatment for unresectable cutaneous lesions respecting the quality of life.

Keywords: cutaneous metastases; electrochemotherapy; in-transit; loco-regional treatments; melanoma

Conflict of interest statement

Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with th

References

  1. BMC Cancer. 2013 Dec 01;13:564 - PubMed
  2. Ann Surg. 2007 Apr;245(4):591-6 - PubMed
  3. Future Oncol. 2014 Apr;10(5):877-90 - PubMed
  4. J Surg Oncol. 2014 Mar;109(3):270-4 - PubMed
  5. Clin Transl Oncol. 2011 Jan;13(1):18-24 - PubMed
  6. Eur J Surg Oncol. 2013 Jan;39(1):4-16 - PubMed
  7. J Dtsch Dermatol Ges. 2013 Nov;11(11):1041-5; quiz 1046 - PubMed
  8. Anticancer Drugs. 2011 Sep;22(8):711-8 - PubMed
  9. Ann Surg Oncol. 2008 Aug;15(8):2215-22 - PubMed
  10. Ecancermedicalscience. 2013 Mar 28;7:294 - PubMed
  11. Br J Surg. 2012 Jun;99(6):821-30 - PubMed
  12. Ann Surg Oncol. 2009 Jan;16(1):191-9 - PubMed
  13. Eur J Surg Oncol. 2008 Feb;34(2):232-40 - PubMed
  14. In Vivo. 2011 Mar-Apr;25(2):265-74 - PubMed
  15. Dermatol Clin. 2012 Jul;30(3):405-12 - PubMed
  16. Dermatol Ther. 2014 May-Jun;27(3):148-52 - PubMed
  17. Annu Rev Biomed Eng. 2014 Jul 11;16:295-320 - PubMed
  18. J Clin Oncol. 2014 Oct 1;32(28):3144-55 - PubMed
  19. Dermatol Surg. 2011 Jun;37(6):816-24 - PubMed
  20. Ann Surg. 2007 Mar;245(3):469-79 - PubMed
  21. Dermatol Surg. 2010 Jul;36(7):1200-2 - PubMed
  22. Expert Rev Anticancer Ther. 2009 Nov;9(11):1611-30 - PubMed
  23. Technol Cancer Res Treat. 2011 Oct;10(5):475-85 - PubMed
  24. J Surg Oncol. 2014 Sep;110(3):320-7 - PubMed
  25. J Surg Oncol. 2014 Mar;109(4):301-7 - PubMed
  26. Acta Physiol Scand. 2003 Apr;177(4):437-47 - PubMed
  27. Expert Rev Anticancer Ther. 2010 May;10(5):729-46 - PubMed
  28. Biomed Eng Online. 2014 Mar 12;13(1):29 - PubMed
  29. Acta Oncol. 2011 Jun;50(5):621-9 - PubMed
  30. Melanoma Res. 2000 Dec;10(6):585-9 - PubMed
  31. Tumori. 2009 May-Jun;95(3):398-402 - PubMed
  32. Med Biol Eng Comput. 2012 Dec;50(12):1213-25 - PubMed
  33. Arch Dermatol Res. 2014 Aug;306(6):521-6 - PubMed
  34. Langenbecks Arch Surg. 2009 Nov;394(6):1079-84 - PubMed
  35. Ann Surg Oncol. 2006 Aug;13(8):1105-12 - PubMed

Publication Types